BioXcel Therapeutics BXCL501 nabs accelerated review in U.S. for agitation in dementia
15 March 2021 - 10:14PM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
BioXcel Therapeutics (NASDAQ:BTAI)
Historical Stock Chart
From Apr 2024 to May 2024
BioXcel Therapeutics (NASDAQ:BTAI)
Historical Stock Chart
From May 2023 to May 2024